- Home
- BMRN
BMRN
BioMarin Pharmaceutical Inc.
as 11-21-2024 4:00pm EST
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | NOVATO |
| Market Cap: | N/A | IPO Year: | 1999 |
| Target Price: | $94.20 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.68 | EPS Growth: | 118.12 |
| 52 Week Low/High: | $61.15 - $99.56 | Next Earning Date: | 10-29-2024 |
| Revenue: | $2,752,809,000 | Revenue Growth: | 19.14% |
| Revenue Growth (this year): | 18.72% | Revenue Growth (next year): | 9.64% |
Stock Insider Trading Activity of BioMarin Pharmaceutical Inc. (BMRN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guyer Charles Greg | BMRN | EVP, Chief Technical Officer | Nov 12 '24 | Sell | $66.37 | 5,278 | $350,323.56 | 68,909 |
Latest BioMarin Pharmaceutical Inc. News
BMRN Breaking Stock News: Dive into BMRN Ticker-Specific Updates for Smart Investing
Zacks
13 hours ago
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
Zacks
2 days ago
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
Insider Monkey
2 days ago
BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
PR Newswire
5 days ago
BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
MT Newswires
7 days ago
Wolfe Research Initiates BioMarin Pharmaceutical at Outperform With $95 Price Target
MT Newswires
7 days ago
Biomarin Pharmaceutical Insider Sold Shares Worth $350,324, According to a Recent SEC Filing
Argus Research
9 days ago
BMRN: What does Argus have to say about BMRN?
Zacks
10 days ago
Implied Volatility Surging for BioMarin Pharmaceutical (BMRN) Stock Options
Compare BMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMRN BioMarin Pharmaceutical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.